CYP7A1 and metabolic dysfunction-associated steatotic liver disease: In T2DM-associated NAFLD, quercetin activates CYP7A1 transcription via mTOR/YY1 pathway suppression, restoring cholesterol homeostasis through enhanced bile acid conversion [115].